196 related articles for article (PubMed ID: 33589748)
101. Repressing
Liu Q; Chen X; Novak MK; Zhang S; Hu W
Elife; 2021 Feb; 10():. PubMed ID: 33599613
[TBL] [Abstract][Full Text] [Related]
102. Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia.
Mosquera Orgueira A; Peleteiro Raíndo A; Cid López M; Antelo Rodríguez B; Díaz Arias JÁ; Ferreiro Ferro R; Alonso Vence N; Bendaña López Á; Abuín Blanco A; Bao Pérez L; Melero Valentín P; González Pérez MS; Cerchione C; Martinelli G; Montesinos Fernández P; Pérez Encinas MM; Bello López JL
PLoS One; 2021; 16(2):e0247093. PubMed ID: 33592069
[TBL] [Abstract][Full Text] [Related]
103. Two faces of RUNX3 in myeloid transformation.
Yokomizo-Nakano T; Sashida G
Exp Hematol; 2021 May; 97():14-20. PubMed ID: 33600870
[TBL] [Abstract][Full Text] [Related]
104. Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma.
Carrasco-Leon A; Ezponda T; Meydan C; Valcárcel LV; Ordoñez R; Kulis M; Garate L; Miranda E; Segura V; Guruceaga E; Vilas-Zornoza A; Alignani D; Pascual M; Amundarain A; Castro-Labrador L; Martín-Uriz PS; El-Omri H; Taha RY; Calasanz MJ; Planes FJ; Paiva B; Mason CE; San Miguel JF; Martin-Subero JI; Melnick A; Prosper F; Agirre X
Leukemia; 2021 May; 35(5):1438-1450. PubMed ID: 33597729
[TBL] [Abstract][Full Text] [Related]
105. One-shot analysis of translated mammalian lncRNAs with AHARIBO.
Minati L; Firrito C; Del Piano A; Peretti A; Sidoli S; Peroni D; Belli R; Gandolfi F; Romanel A; Bernabo P; Zasso J; Quattrone A; Guella G; Lauria F; Viero G; Clamer M
Elife; 2021 Feb; 10():. PubMed ID: 33594971
[TBL] [Abstract][Full Text] [Related]
106. High expression of CD56 may be associated with favorable overall survival in intermediate-risk acute myeloid leukemia.
Chen C; Chio CL; Zeng H; Li Y
Hematology; 2021 Dec; 26(1):210-214. PubMed ID: 33594945
[TBL] [Abstract][Full Text] [Related]
107. Treatment-induced arteriolar revascularization and miR-126 enhancement in bone marrow niche protect leukemic stem cells in AML.
Zhang B; Nguyen LXT; Zhao D; Frankhouser DE; Wang H; Hoang DH; Qiao J; Abundis C; Brehove M; Su YL; Feng Y; Stein A; Ghoda L; Dorrance A; Perrotti D; Chen Z; Han A; Pichiorri F; Jin J; Jovanovic-Talisman T; Caligiuri MA; Kuo CJ; Yoshimura A; Li L; Rockne RC; Kortylewski M; Zheng Y; Carlesso N; Kuo YH; Marcucci G
J Hematol Oncol; 2021 Aug; 14(1):122. PubMed ID: 34372909
[TBL] [Abstract][Full Text] [Related]
108. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner.
Feng M; Xie X; Han G; Zhang T; Li Y; Li Y; Yin R; Wang Q; Zhang T; Wang P; Hu J; Cheng Y; Gao Z; Wang J; Chang J; Cui M; Gao K; Chai J; Liu W; Guo C; Li S; Liu L; Zhou F; Chen J; Zhang H
Blood; 2021 Jul; 138(1):71-85. PubMed ID: 33763698
[TBL] [Abstract][Full Text] [Related]
109. Outcome of secondary acute myeloid leukemia treated with hypomethylating agent plus venetoclax (HMA-Ven) or liposomal daunorubicin-cytarabine (CPX-351).
Salhotra A; Aribi A; Ngo D; Zhang J; Sandhu K; Al-Malki M; Ali H; Koller P; Arslan S; Budde E; Khaled S; Dadwal S; Snyder DS; Artz A; Forman S; Nakamura R; Stein A; Marcucci G; Aldoss I; Pullarkat V
Am J Hematol; 2021 Jun; 96(6):E196-E200. PubMed ID: 33719090
[No Abstract] [Full Text] [Related]
110. OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia.
Eisfelder BJ; Saygin C; Wynne J; Colton MW; Fischietti M; Beauchamp EM; Cheng JX; Odenike O; Roboz G; Alachkar H; Stock W
Blood Cancer J; 2021 Mar; 11(3):48. PubMed ID: 33658483
[TBL] [Abstract][Full Text] [Related]
111. Leveraging the replication-competent avian-like sarcoma virus/tumor virus receptor-A system for modeling human gliomas.
Kanvinde PP; Malla AP; Connolly NP; Szulzewsky F; Anastasiadis P; Ames HM; Kim AJ; Winkles JA; Holland EC; Woodworth GF
Glia; 2021 Sep; 69(9):2059-2076. PubMed ID: 33638562
[TBL] [Abstract][Full Text] [Related]
112. Dysregulation of miR-138-5p/RPS6KA1-AP2M1 Is Associated With Poor Prognosis in AML.
Yu DH; Chen C; Liu XP; Yao J; Li S; Ruan XL
Front Cell Dev Biol; 2021; 9():641629. PubMed ID: 33732707
[TBL] [Abstract][Full Text] [Related]
113. ATM and ATR Activation Through Crosstalk Between DNA Damage Response Pathways.
Fedak EA; Adler FR; Abegglen LM; Schiffman JD
Bull Math Biol; 2021 Mar; 83(4):38. PubMed ID: 33704589
[TBL] [Abstract][Full Text] [Related]
114. Prognostic Value of MicroRNA-20b in Acute Myeloid Leukemia.
Cheng Z; Dai Y; Huang W; Zhong Q; Zhu P; Zhang W; Wu Z; Lin Q; Zhu H; Cui L; Qian T; Deng C; Fu L; Liu Y; Zeng T
Front Oncol; 2020; 10():553344. PubMed ID: 33680910
[TBL] [Abstract][Full Text] [Related]
115. Long noncoding RNA DANCR confers cytarabine resistance in acute myeloid leukemia by activating autophagy via the miR-874-3P/ATG16L1 axis.
Zhang H; Liu L; Chen L; Liu H; Ren S; Tao Y
Mol Oncol; 2021 Apr; 15(4):1203-1216. PubMed ID: 33638615
[TBL] [Abstract][Full Text] [Related]
116. How signalling games explain mimicry at many levels: from viral epidemiology to human sociology.
Casey W; Massey SE; Mishra B
J R Soc Interface; 2021 Feb; 18(175):20200689. PubMed ID: 33622145
[TBL] [Abstract][Full Text] [Related]
117. Concepts and Applications of Information Theory to Immuno-Oncology.
Karolak A; Branciamore S; McCune JS; Lee PP; Rodin AS; Rockne RC
Trends Cancer; 2021 Apr; 7(4):335-346. PubMed ID: 33618998
[TBL] [Abstract][Full Text] [Related]
118. Convection-enhanced drug delivery for glioblastoma: a review.
D'Amico RS; Aghi MK; Vogelbaum MA; Bruce JN
J Neurooncol; 2021 Feb; 151(3):415-427. PubMed ID: 33611708
[TBL] [Abstract][Full Text] [Related]
119. Design and Characterization of an Intracellular Covalent Ligand for CC Chemokine Receptor 2.
Ortiz Zacarías NV; Chahal KK; Šimková T; van der Horst C; Zheng Y; Inoue A; Theunissen E; Mallee L; van der Es D; Louvel J; IJzerman AP; Handel TM; Kufareva I; Heitman LH
J Med Chem; 2021 Mar; 64(5):2608-2621. PubMed ID: 33600174
[TBL] [Abstract][Full Text] [Related]
120. Targeting miR-126 in inv(16) acute myeloid leukemia inhibits leukemia development and leukemia stem cell maintenance.
Zhang L; Nguyen LXT; Chen YC; Wu D; Cook GJ; Hoang DH; Brewer CJ; He X; Dong H; Li S; Li M; Zhao D; Qi J; Hua WK; Cai Q; Carnahan E; Chen W; Wu X; Swiderski P; Rockne RC; Kortylewski M; Li L; Zhang B; Marcucci G; Kuo YH
Nat Commun; 2021 Oct; 12(1):6154. PubMed ID: 34686664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
